- Report
- August 2024
- 143 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 173 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- November 2024
- 164 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- January 2025
- 280 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- August 2024
- 87 Pages
Europe
From €1426EUR$1,500USD£1,198GBP
- Report
- September 2024
- 80 Pages
India
From €3327EUR$3,500USD£2,795GBP
- Report
- December 2023
- 117 Pages
Asia Pacific
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2024
- 158 Pages
Global
From €4040EUR$4,250USD£3,394GBP
The Waterborne Disease market within the context of Infectious Disease Testing is focused on the detection and diagnosis of waterborne pathogens. These pathogens can be found in contaminated water sources, such as rivers, lakes, and oceans, and can cause a variety of illnesses, including gastrointestinal, respiratory, and skin infections. Testing for waterborne diseases is important for public health, as it can help identify and prevent outbreaks.
Testing for waterborne diseases typically involves the use of molecular techniques, such as PCR and ELISA, as well as traditional culture-based methods. These tests can detect a wide range of pathogens, including bacteria, viruses, and parasites.
The Waterborne Disease market is highly competitive, with a number of companies offering testing services. These include Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Luminex Corporation. Show Less Read more